These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 23407399)
1. Screening for anxiety symptoms in Parkinson disease: a cross-sectional study. Stefanova E; Ziropadja L; Petrović M; Stojković T; Kostić V J Geriatr Psychiatry Neurol; 2013 Mar; 26(1):34-40. PubMed ID: 23407399 [TBL] [Abstract][Full Text] [Related]
2. Designing a new scale to measure anxiety symptoms in Parkinson's disease: item selection based on canonical correlation analysis. Martinez-Martin P; Rojo-Abuin JM; Dujardin K; Pontone GM; Weintraub D; Forjaz MJ; Starkstein S; Leentjens AF Eur J Neurol; 2013 Aug; 20(8):1198-203. PubMed ID: 23581431 [TBL] [Abstract][Full Text] [Related]
3. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Leentjens AF; Dujardin K; Marsh L; Richard IH; Starkstein SE; Martinez-Martin P Mov Disord; 2011 Feb; 26(3):407-15. PubMed ID: 21384425 [TBL] [Abstract][Full Text] [Related]
4. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662 [TBL] [Abstract][Full Text] [Related]
5. Apathy and depression in Parkinson's disease: the Belgrade PD study report. Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396 [TBL] [Abstract][Full Text] [Related]
6. The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale. Leentjens AF; Dujardin K; Pontone GM; Starkstein SE; Weintraub D; Martinez-Martin P Mov Disord; 2014 Jul; 29(8):1035-43. PubMed ID: 24862344 [TBL] [Abstract][Full Text] [Related]
7. Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Nègre-Pagès L; Grandjean H; Lapeyre-Mestre M; Montastruc JL; Fourrier A; Lépine JP; Rascol O; Mov Disord; 2010 Jan; 25(2):157-66. PubMed ID: 19950403 [TBL] [Abstract][Full Text] [Related]
8. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study. Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU; J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of major depression in Belgian parkinsonian patients. Vanderheyden JE; Gonce M; Bourgeois P; Cras P; De Nayer AR; Flamez A; Supiot F; Donneau AF; Albert A; Berlaimont V; Acta Neurol Belg; 2010 Jun; 110(2):148-56. PubMed ID: 20873444 [TBL] [Abstract][Full Text] [Related]
11. Clinical correlates of anhedonia in patients with Parkinson's disease. Matsui K; Tachibana H; Yamanishi T; Oguru M; Toda K; Okuda B; Oka N Clin Neurol Neurosurg; 2013 Dec; 115(12):2524-7. PubMed ID: 24252163 [TBL] [Abstract][Full Text] [Related]
12. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease. Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408 [TBL] [Abstract][Full Text] [Related]
13. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737 [TBL] [Abstract][Full Text] [Related]
14. The association of apathy with central fatigue perception in patients with Parkinson's disease. Sáez-Francàs N; Hernández-Vara J; Corominas Roso M; Alegre Martín J; Casas Brugué M Behav Neurosci; 2013 Apr; 127(2):237-44. PubMed ID: 23339489 [TBL] [Abstract][Full Text] [Related]
15. [Neuropsychiatric problems in patients with Parkinson's disease]. Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846 [TBL] [Abstract][Full Text] [Related]
16. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms. Klepac N; Hajnsek S; Trkulja V J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416 [TBL] [Abstract][Full Text] [Related]
17. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease. Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ; Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672 [TBL] [Abstract][Full Text] [Related]
18. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Leentjens AF; Dujardin K; Marsh L; Martinez-Martin P; Richard IH; Starkstein SE Mov Disord; 2011 Feb; 26(3):484-92. PubMed ID: 21312281 [TBL] [Abstract][Full Text] [Related]
19. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study. Rektorova I; Balaz M; Svatova J; Zarubova K; Honig I; Dostal V; Sedlackova S; Nestrasil I; Mastik J; Bares M; Veliskova J; Dusek L Clin Neuropharmacol; 2008; 31(5):261-6. PubMed ID: 18836343 [TBL] [Abstract][Full Text] [Related]
20. Psychiatric symptoms screening in the early stages of Parkinson's disease. Bugalho P; da Silva JA; Cargaleiro I; Serra M; Neto B J Neurol; 2012 Jan; 259(1):124-31. PubMed ID: 21691730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]